<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02183116</url>
  </required_header>
  <id_info>
    <org_study_id>107.228</org_study_id>
    <nct_id>NCT02183116</nct_id>
  </id_info>
  <brief_title>A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the Knee</brief_title>
  <official_title>Open Study to Access the Efficacy and Safety of Meloxicam 7.5mg in Patients With Osteoarthritis of the Knee</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boehringer Ingelheim</source>
  <brief_summary>
    <textblock>
      To Access the Efficacy and Safety of Meloxicam 7.5mg once daily over a treatment period of 56
      days
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 1998</start_date>
  <primary_completion_date type="Actual">February 1999</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in pain on active movement assessed by a 100 mm visual analogue scale (100 mm, VAS)</measure>
    <time_frame>Baseline, 8 weeks after first drug administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Lequesne index</measure>
    <time_frame>Baseline, 8 weeks after first drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in physical examination (tenderness)</measure>
    <time_frame>Baseline, 8 weeks after first drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of significant change from baseline in status according endoscopy</measure>
    <time_frame>Baseline, 8 weeks after first drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of significant change from baseline in gastrointestinal (GI) symptoms score</measure>
    <time_frame>Baseline, 8 weeks after first drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of significant change from baseline in laboratory values</measure>
    <time_frame>Baseline, 8 weeks after first drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients with Adverse Events</measure>
    <time_frame>Up to 8 weeks after first drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of significant change from baseline in physical examination (swelling)</measure>
    <time_frame>Baseline, 8 weeks after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Meloxicam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Meloxicam</intervention_name>
    <arm_group_label>Meloxicam</arm_group_label>
    <other_name>Mobic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Osteoarthritis of the knee requiring the therapy with non-steroidal anti-inflammatory
        drugs (NSAIDs)

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>34 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2014</study_first_submitted>
  <study_first_submitted_qc>July 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2014</study_first_posted>
  <last_update_submitted>July 4, 2014</last_update_submitted>
  <last_update_submitted_qc>July 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meloxicam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

